Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
755 trials across Europe, recruiting first
Laroprovstat/rosuvastatin versus rosuvastatin for lowering LDL‑C in patients with high cholesterol
GermanyA Phase 2 Study of MZE782 Safety, Tolerability, and Efficacy in Adults with Phenylketonuria
FrancePhase 3 Study of Oral Orforglipron vs Weekly Dulaglutide in Children and Adolescents (10‑<18 years) with Type 2 Diabetes
BelgiumPhase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
BelgiumLong‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes
BulgariaStudy of AZD6234 (lenbelintide) Added to Incretin Therapy in Adults with Obesity or Overweight and a Weight‑Related Comorbidity, With or Without Type 2 Diabetes
DenmarkPhase 2b Randomized Study of Semaglutide Subcutaneous Depot for Weight Reduction in Adults with Obesity or Overweight
GermanyA Phase 3 Study of Once‑Monthly PF‑08653944 vs Placebo for Weight Loss in Adults with Overweight or Obesity
FranceEfficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing's syndrome
BulgariaEfficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes
GermanyEfficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity
BelgiumResistance Training to Preserve Thigh Muscle Volume in Adults with Obesity Treated with Tirzepatide (Phase IV Randomized Trial)
GermanyThe therapies tested most often in Metabolism and nutrition disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
